United States · FDA National Drug Code directory
Myrbetriq
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0469-2601_fe8998d8-cf08-4e07-b966-33e8de20abf1
- Product NDC
- 0469-2601
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- mirabegron
- Labeler
- Astellas Pharma US, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20120628
- Source listing expiry
- 20261231
Source-listed ingredients
- MIRABEGRON — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 CARTON in 1 TRAY (0469-2601-07) / 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · 0469-2601-07
- 1 BOTTLE in 1 CARTON (0469-2601-30) / 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · 0469-2601-30
- 1 BOTTLE in 1 CARTON (0469-2601-90) / 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · 0469-2601-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →